The TMEM242 antibody is a research tool designed to detect and study the transmembrane protein 242 (TMEM242), a mitochondrial protein involved in ATP synthase assembly and respiratory chain function . This antibody is widely used in molecular biology to investigate TMEM242's role in mitochondrial dynamics, energy production, and its regulatory effects on coagulation pathways in model organisms like zebrafish .
TMEM242 interacts with TMEM70 and the mitochondrial complex I assembly (MCIA) complex to facilitate ATP synthase rotor ring (c-ring) assembly .
Key observations from knockout studies1:
Deletion of TMEM242 reduces ATP synthase levels by ~50% and impairs incorporation of subunits ATP6, ATP8, j, and k.
Combined deletion of TMEM242 and TMEM70 abolishes ATP synthase assembly entirely.
Respiratory complexes I, III, and IV are also destabilized in TMEM242-deficient cells.
| Parameter | Effect of TMEM242 Knockdown |
|---|---|
| Bleeding Phenotype | Increased gill bleeding |
| Coagulation | Delayed fibrin/thrombus formation |
| ROS Levels | Elevated reactive oxygen species (ROS) |
| Clotting Factors | ↑ f5, f7, f9a (↓ f8) |
| Transcription Factors | ↑ Sirt6, Nrf2; regulates f9a via ROS signaling |
Mechanistic link: TMEM242 deficiency disrupts ATP synthase, elevating ROS and activating sirt6 and nrf2, which drive coagulation factor overexpression .
Topography: TMEM242 is an integral IMM protein with N- and C-termini facing the mitochondrial matrix .
Molecular Interactions:
KEGG: dre:569632
UniGene: Dr.85638
TMEM242 (Transmembrane Protein 242) is an integral membrane protein localized in the mitochondrial inner membrane. Research has established that TMEM242 plays a crucial role in the assembly of the ATP synthase rotor ring . This protein is embedded in cell membranes as a multi-pass membrane protein with both N- and C-terminal regions facing the mitochondrial matrix . TMEM242 has gained importance in mitochondrial research due to its involvement in energy metabolism and potential implications in conditions related to mitochondrial dysfunction and hemostasis .
Currently, researchers have access to several TMEM242 antibodies with different specifications:
| Antibody | Type | Host | Target Region | Validated Applications | Reactivity | Concentration |
|---|---|---|---|---|---|---|
| STJ195130 | Polyclonal | Rabbit | 53-103 aa | Western Blot | Human/Mouse | 1 mg/mL |
| HPA025764 | Polyclonal | Rabbit | Not specified | IHC, ICC-IF, WB | Human | 0.05 mg/mL |
These antibodies are designed specifically for research applications and are not intended for diagnostic or therapeutic use .
TMEM242 localizes exclusively to mitochondria, specifically to the mitochondrial inner membrane. To confirm this localization in your research:
Subcellular fractionation: Studies have demonstrated that TMEM242 is found uniquely in mitochondrial fractions through examination of subcellular fractions .
Immunofluorescence microscopy: Use TMEM242 antibodies with co-staining of established mitochondrial markers to visualize localization in cell lines such as HeLa cells .
Membrane association testing: TMEM242 is not removed from mitochondria by washing at alkaline pH, confirming it as an integral membrane protein rather than a peripheral membrane protein .
Detergent extraction: TMEM242 can be extracted with buffer containing deoxycholate concentrations of 0.5% or greater, similar to other known inner mitochondrial membrane (IMM) components .
Topology determination: Trypsinolysis of intact and lysed mitochondria has confirmed that both N- and C-terminal regions of TMEM242 are located in the mitochondrial matrix .
For optimal Western blotting results with TMEM242 antibodies:
| Antibody | Recommended Dilution | Buffer Composition | Storage Condition | Sample Preparation |
|---|---|---|---|---|
| STJ195130 | 1:500-2000 | PBS with 50% Glycerol, 0.5% BSA, 0.02% Sodium Azide | -20°C for up to 1 year | Mitochondrial fraction recommended |
When preparing samples, remember that TMEM242 is an integral membrane protein requiring appropriate detergents for extraction. The antibody was affinity-purified using epitope-specific immunogen, which contributes to its specificity for endogenous levels of TMEM242 .
Historically, studying TMEM242 has been challenging due to the limited availability of specific antibodies. In earlier research, it was noted that "it was not possible to confirm by immunodetection that TMEM242 was bound to TMEM70-t, as no antibody against TMEM242 is currently available" . This limitation required researchers to use tagged versions of TMEM242 (C-terminal or N-terminal tagged constructs) to study its interactions and localization . The recent development of commercial antibodies against TMEM242 now enables direct detection of the endogenous protein, facilitating more straightforward research approaches.
When designing experiments to study TMEM242's role in ATP synthase assembly:
Generate knockout cell lines: Use CRISPR-Cas9 to create TMEM242 knockout cell lines. The established methodology used in previous studies involved disrupting TMEM242 in various cell lines including HAP1-WT, HAP1-ΔTMEM70, and HEK293-Δδ cells .
Create tagged protein constructs: Develop stable cell lines expressing tagged versions of TMEM242 (TMEM242-t or TMEM242-Nt) for interaction studies. Use the Flp-In T-REx system with plasmids derived from pcDNA5/FRT/TO for controlled expression .
Analyze oligomeric states: Employ Clear Native PAGE (CN-PAGE) followed by Western blotting to examine how TMEM242 deletion affects ATP synthase and vestigial complexes .
Purify complexes: Isolate ATP synthase and associated complexes from mitochondria or mitoplasts using affinity purification of tagged proteins .
Perform quantitative mass spectrometry: Use stable isotope labeling in cell culture (SILAC) combined with MS analysis of trypsin and chymotrypsin digests to identify and quantify changes in protein interactions .
Assess functional outcomes: Monitor cell proliferation using Incucyte HD instruments and measure oxygen consumption with Seahorse XF e24 analyzers to determine the functional consequences of TMEM242 manipulation .
Research in zebrafish has revealed that knockdown of tmem242 increases reactive oxygen species (ROS) levels, which subsequently affects downstream pathways . To investigate this relationship:
Knockdown efficiency verification: First, verify knockdown efficiency using qRT-PCR with gene-specific primers. In zebrafish studies, >95% knockdown efficiency was achieved .
ROS measurement: After TMEM242 knockdown, measure ROS levels using appropriate assays. In previous studies, researchers found that inhibition of ATP synthase with oligomycin elevated ROS levels, suggesting that TMEM242's role in ATP synthase assembly directly impacts ROS production .
Pathway analysis: Investigate the downstream effects by examining the expression of ROS-responsive genes. Research has shown increased mRNA levels of sirt6 and nrf2 after tmem242 knockdown, suggesting these are key mediators in the response pathway .
Validation through inhibition studies: Perform ROS inhibition experiments to confirm the causal relationship. Studies have shown that ROS inhibition reduces expression of downstream targets like f9a, supporting the ROS-mediated regulation hypothesis .
Functional consequences assessment: Evaluate the physiological outcomes, such as altered coagulation factor expression or bleeding tendency, which may result from TMEM242 depletion and subsequent ROS elevation .
To study TMEM242's interactions with other proteins:
Co-immunoprecipitation: Use TMEM242 antibodies to pull down native protein complexes. Previous research successfully used tagged versions of TMEM242 to identify interactions with TMEM70, subunit c, ACAD9, NDUFAF1, and weakly with TIMMDC1 .
Reciprocal co-IP validation: Confirm interactions by performing reverse co-IPs with antibodies against putative partner proteins. For example, subunit c was found associated with TMEM70-t in HEK293-Δδ cells .
Controls for specificity:
Use TMEM242 knockout cells as negative controls
Include isotype control antibodies to rule out non-specific binding
Perform pre-clearing of lysates to reduce background
Detergent optimization: Since TMEM242 is a membrane protein, carefully select detergents that solubilize the protein without disrupting key interactions. Previous research showed deoxycholate at ≥0.5% effectively extracts TMEM242 .
Analysis of interactome changes: Compare interacting partners under different conditions, such as oxidative stress or ATP synthase inhibition, to understand context-dependent interactions.
Recent research in zebrafish has uncovered an unexpected role for tmem242 in hemostasis and coagulation pathways . When investigating this aspect:
Screening approach: Begin with a functional screening approach such as the gill bleeding assay used in zebrafish after knockdown of tmem242. This can identify if there is a hemostasis phenotype .
| Screening Result | Control | tmem242 Knockdown |
|---|---|---|
| Gill Bleeding | Normal | Significantly increased |
| Thrombocyte Count | Baseline | No significant change |
| Whole Blood Aggregation | Normal | No significant difference |
Pathway analysis: Determine which specific coagulation pathways are affected using assays like kinetic partial thromboplastin time (kPTT) and kinetic prothrombin time (kPT) .
Gene expression analysis: Quantify mRNA levels of coagulation factors after TMEM242 knockdown. Zebrafish studies revealed elevated mRNA levels of several clotting factor genes, including f5, f7, and f9a, while f8 was not affected .
Mechanistic connection: Investigate the link between mitochondrial function and coagulation through the ROS-sirt6-nrf2 pathway. Research has shown that tmem242 knockdown increases ROS levels, which upregulates sirt6 and nrf2, potentially leading to increased coagulation factor transcripts and DIC-like bleeding tendencies .
Confirmatory experiments: Perform knockdown of regulatory factors (sirt6, nrf2) and observe effects on coagulation factor levels to confirm the proposed mechanistic pathway .
For optimal detection of TMEM242 by immunofluorescence:
Fixation protocol: Use 4% paraformaldehyde fixation for 10-15 minutes at room temperature to preserve mitochondrial morphology.
Permeabilization optimization: For mitochondrial inner membrane proteins like TMEM242, use 0.2% Triton X-100 for 10 minutes to ensure antibody access to the target.
Mitochondrial counterstaining: Always co-stain with established mitochondrial markers (e.g., MitoTracker or antibodies against TOM20) to confirm mitochondrial localization, as demonstrated in previous studies .
Signal amplification: If signal intensity is low, consider using biotin-streptavidin amplification systems or tyramide signal amplification.
Imaging parameters: Use high-resolution confocal microscopy with appropriate z-sectioning to capture the three-dimensional organization of mitochondria.
Controls: Include TMEM242 knockout cells as negative controls and cells overexpressing tagged TMEM242 as positive controls to validate staining specificity.
When facing non-specific binding:
Antibody titration: Test multiple dilutions to identify the optimal concentration that maximizes specific signal while minimizing background.
Blocking optimization: Extend blocking time (1-2 hours at room temperature) using 5% BSA or 5% normal serum from the same species as the secondary antibody.
Pre-adsorption: If available, pre-incubate the antibody with the immunizing peptide to confirm specificity; specific signals should be eliminated.
Wash optimization: Increase the number and duration of washes with PBS containing 0.1% Tween-20 to reduce non-specific binding.
Cross-reactivity testing: Test the antibody on TMEM242 knockout cells to identify any cross-reactive signals that persist despite the absence of the target protein.
Secondary antibody controls: Include controls with secondary antibody only to identify background from the detection system.
Thorough validation of TMEM242 antibodies is crucial for reliable results:
Western blot analysis: Confirm a single band at the expected molecular weight for TMEM242 (~25-30 kDa) in mitochondrial fractions.
Genetic validation:
Test on TMEM242 knockout cells (negative control)
Test on cells overexpressing TMEM242 (positive control)
Compare signal intensities in cells with varying endogenous expression levels
Peptide competition: Pre-incubate the antibody with the immunizing peptide; specific signals should be blocked.
Subcellular localization: Confirm exclusive mitochondrial localization as previously demonstrated .
Cross-species reactivity: If working with non-human models, verify reactivity with the species of interest. Current commercial antibodies are validated for human and mouse TMEM242 .
Multiple antibody validation: When possible, compare results using antibodies targeting different epitopes of TMEM242 to confirm consistent findings.
TMEM242's role in ATP synthase assembly makes it relevant for mitochondrial disorder research:
Patient sample analysis: Use TMEM242 antibodies to compare protein levels and localization in control versus patient samples, particularly for disorders involving ATP synthase dysfunction.
Biomarker potential: Investigate whether altered TMEM242 expression, localization, or post-translational modifications correlate with specific mitochondrial pathologies.
Therapeutic target assessment: For disorders involving elevated ROS, TMEM242 may represent a potential therapeutic target given its role in ROS regulation demonstrated in zebrafish models .
Functional analysis in patient-derived cells: Use TMEM242 antibodies to investigate ATP synthase assembly in fibroblasts or induced pluripotent stem cells from patients with mitochondrial disorders.
Genetic screening correlation: Compare TMEM242 protein levels with genetic variants identified in patients to establish genotype-phenotype correlations.
Research suggests TMEM242 may be involved in cellular stress responses through its effects on ROS:
Stress-induced changes: Monitor TMEM242 expression, localization, or post-translational modifications under various cellular stresses (oxidative stress, hypoxia, nutrient deprivation).
Mitochondrial dynamics: Investigate how TMEM242 levels correlate with changes in mitochondrial morphology, fusion/fission, or mitophagy during stress responses.
Adaptive responses: Study how cells adapt to TMEM242 deficiency through compensatory mechanisms, potentially providing insights into mitochondrial stress adaptation pathways.
ROS signaling pathways: Use TMEM242 antibodies to track how the protein's levels or modifications influence downstream ROS-responsive factors like sirt6 and nrf2, which were shown to be upregulated after tmem242 knockdown in zebrafish .
Cross-talk with other cellular compartments: Investigate potential communication between mitochondria and other organelles mediated by TMEM242-dependent ROS signaling.
TMEM242's conservation across species makes it interesting for developmental and evolutionary studies:
Developmental expression patterns: Use TMEM242 antibodies to track expression during embryonic development, particularly in tissues with high mitochondrial content.
Evolutionary conservation: Compare TMEM242 expression, localization, and function across diverse species to understand evolutionary conservation of mitochondrial assembly mechanisms.
Tissue-specific functions: Investigate potential tissue-specific roles of TMEM242, particularly in tissues affected by mitochondrial disorders or those with specialized mitochondrial functions.
Zebrafish model applications: Building on existing zebrafish research , use TMEM242 antibodies to further characterize the protein's role in development and hemostasis across different developmental stages.
Comparative analysis: Analyze differences in TMEM242 expression or localization between species with different metabolic requirements to gain insights into its adaptive significance.
Phospho-specific antibodies could reveal regulatory mechanisms of TMEM242:
Phosphorylation site identification: First, phosphoproteomic studies should identify specific residues that undergo phosphorylation under various conditions.
Functional relevance: Determine how phosphorylation affects TMEM242's function in ATP synthase assembly and ROS regulation before developing site-specific antibodies.
Development strategy: Generate antibodies against synthetic phosphopeptides corresponding to identified phosphorylation sites, with careful validation using phosphatase-treated samples and phosphomimetic mutants.
Applications: Such antibodies could reveal how signaling pathways regulate TMEM242 function and potentially connect mitochondrial function to broader cellular signaling networks.
The unexpected link between TMEM242 and coagulation pathways discovered in zebrafish opens new research avenues:
Confirmation in mammalian systems: Use TMEM242 antibodies to investigate whether the mitochondria-coagulation link is conserved in mammalian systems.
Mechanistic pathway dissection: Trace the signaling cascade from TMEM242 deficiency to altered coagulation factor expression, focusing on the proposed ROS-sirt6-nrf2 pathway .
Clinical relevance: Investigate TMEM242 expression in patients with coagulation disorders, particularly those with unexplained disseminated intravascular coagulation (DIC)-like presentations.
Therapeutic implications: If the pathway is conserved, targeting components of the TMEM242-ROS-coagulation axis might offer new therapeutic approaches for certain coagulation disorders.